Your shopping cart is currently empty

OTUB2-IN-1 is a selective OTUB2 inhibitor with anti-tumor activity that inhibits the expression of PD-L1 protein in tumor cells and inhibits tumor growth, and can be used to study skin cancer and non-small cell lung cancer (NSCLC).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $483 | - | In Stock | |
| 10 mg | $692 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock | |
| 100 mg | $1,970 | - | In Stock |
| Description | OTUB2-IN-1 is a selective OTUB2 inhibitor with anti-tumor activity that inhibits the expression of PD-L1 protein in tumor cells and inhibits tumor growth, and can be used to study skin cancer and non-small cell lung cancer (NSCLC). |
| In vitro | Incubation of recombinant GST-OTUB2 protein with OTUB2-IN-1 resulted in significant inhibition of Ub-R110 cleavage by GST-OTUB2 in a dose-dependent manner, suggesting that OTUB2-IN-1 can inhibit the hydrolytic activity of recombinant GST-OTUB2 protein toward its substrate Ub-R110 in vitro. [1] |
| In vivo | Evaluated the therapeutic potential of OTUB2-IN-1 using a mouse LL/2 tumor model. OTUB2-IN-1 treatment significantly suppressed tumor growth and prolonged mouse survival, and no obvious toxicity was observed. To clarify the effect of OTUB2-IN-1 in tumor inhibition through regulation of PD-L1 in vivo, LL/2 cells with stably expressed PD-L1 and control plasmids were used to establish a tumor model. As expected, in comparison to the control group, overexpressed PD-L1 resulted in a substantial increase in tumor growth, whereas OTUB2-IN-1 significantly reduced the PD-L1-overexpressing tumor growth. [1] |
| Molecular Weight | 434.49 |
| Formula | C19H18N2O6S2 |
| Smiles | O=C(O)CN(C(/C1=C2C(N(CCCCCC(O)=O)C(S\2)=S)=O)=O)C3=C1C=CC=C3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (92.06 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.